Dopaminergic antagonists: effects of 1,2,3,4-tetrahydroisoquinoline and its N-methyl and N-propyl homologs on apomorphine- and L-dopa-induced behavioral effects in rodents
- PMID: 571017
Dopaminergic antagonists: effects of 1,2,3,4-tetrahydroisoquinoline and its N-methyl and N-propyl homologs on apomorphine- and L-dopa-induced behavioral effects in rodents
Abstract
N-Methyl-1,2,3,4-tetrahydroisoquinoline (MTIQ) antagonized apomorphine (APO)-induced stereotypy in a dose-related manner when injected i.p. in rats and attenuated L-dopa-induced hyperactivity in mice. 1,2,3,4-Tetrahydroisoquinoline (TIQ) and its homolog, N-n-propyl-, also blocked APO-induced stereotypy when given similarly. No significant difference was found between the amounts of radioactivity in the brain homogenates of MTIQ- and saline-pretreated rats after injection with [3H] APO. This suggested that MTIQ did not antagonize the behavioral effects of APO by blocking its entry into the brain. Mice fed ad libitum for 90 days with Purina Chow mixed with TIQ (5.0 mg/g) displayed behavioral supersensitivity in comparison with controls when injected with L-dopa (0.40 g/kg i.p.) after pretreatment with carbidopa. This was parallelled by a significant increase of dopamine-related adenylate cyclase activity measured in homogenates of caudate nuclei. The similarity between the behavioral effects induced by some neuroleptics and those observed with TIQ and its homologs suggests that the latter may be a new class of short-acting neuroleptics.
Similar articles
-
RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.J Pharmacol Exp Ther. 1983 Jan;224(1):161-70. J Pharmacol Exp Ther. 1983. PMID: 6401334
-
Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.J Pharmacol Exp Ther. 1983 May;225(2):337-45. J Pharmacol Exp Ther. 1983. PMID: 6682440
-
Pharmacologic profile of a novel potent direct-acting dopamine agonist, (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO].J Pharmacol Exp Ther. 1984 Sep;230(3):569-76. J Pharmacol Exp Ther. 1984. PMID: 6433000
-
Cholinergic effects of molecular segments of apomorphine and dopaminergic effects of N,N-dialkylated dopamines.J Med Chem. 1975 Dec;18(12):1194-1200. doi: 10.1021/jm00246a005. J Med Chem. 1975. PMID: 1238569
-
Effects of some antidepressant drugs on apomorphine concentration in the central nervous system of rats and apomorphine-induced stereotypy.Pol J Pharmacol Pharm. 1985 Jul-Aug;37(4):509-15. Pol J Pharmacol Pharm. 1985. PMID: 3866221
Cited by
-
Salsolinol, an endogenous compound triggers a two-phase opposing action in the central nervous system.Neurotox Res. 2015 Apr;27(3):300-13. doi: 10.1007/s12640-014-9511-y. Epub 2014 Dec 24. Neurotox Res. 2015. PMID: 25537852 Free PMC article.
-
Salsolinol: an Unintelligible and Double-Faced Molecule-Lessons Learned from In Vivo and In Vitro Experiments.Neurotox Res. 2018 Feb;33(2):485-514. doi: 10.1007/s12640-017-9818-6. Epub 2017 Oct 23. Neurotox Res. 2018. PMID: 29063289 Free PMC article. Review.
-
Pro-cognitive effect of 1MeTIQ on recognition memory in the ketamine model of schizophrenia in rats: the behavioural and neurochemical effects.Psychopharmacology (Berl). 2020 Jun;237(6):1577-1593. doi: 10.1007/s00213-020-05484-1. Epub 2020 Feb 20. Psychopharmacology (Berl). 2020. PMID: 32076746 Free PMC article.
-
A possible physiological role for cerebral tetrahydroisoquinolines.Neurotox Res. 2003;5(1-2):147-55. doi: 10.1007/BF03033379. Neurotox Res. 2003. PMID: 12832229 Review.
-
1MeTIQ and olanzapine, despite their neurochemical impact, did not ameliorate performance in fear conditioning and social interaction tests in an MK-801 rat model of schizophrenia.Pharmacol Rep. 2021 Apr;73(2):490-505. doi: 10.1007/s43440-020-00209-9. Epub 2021 Jan 6. Pharmacol Rep. 2021. PMID: 33403530 Free PMC article.